Ali Asghar Sarchahi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ali Asghar Sarchahi has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
Hadi Mohebalian
Department of Pathobiology Faculty of Veterinary Medicine Ferdowsi University of Mashhad Mashhad Iran
5 shared publicationsMohammad Arbabi
Graduated from Faculty of Veterinary Medicine Ferdowsi University of Mashhad Mashhad Iran
5 shared publications- Akos Pakozdy
Clinical Unit of Internal Medicine Small Animals, University of Veterinary Medicine, Vienna, Austria
2 shared publications - Azizollah Khodakaram Tafti
Department of Pathobiology, School of Veterinary Medicine, Shiraz University, Shiraz, Iran
2 shared publications - Hossein Kazemi Mehrjerdi
Department of Clinical Sciences, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran
2 shared publications Michael Leschnik
Department for Companion Animals and Horses, Small Animal Clinic, Internal Medicine, University of Veterinary Medicine, Vienna, Austria
2 shared publications
Latest Publications
- Open Access
- 28 April 2026
- Published by Wiley in Veterinary Medicine and Science
- Vol. 12 (3) , e70952
Neurological Disorders in Dogs: A Retrospective Analysis of Prevalence, Aetiology, Lesion Locations, and Regional Variations in Northeastern Iran
Background: Neurological disorders in dogs are a significant concern in veterinary medicine and affect various breeds and ages. Previous studies have reported differing prevalence rates and aetiologies across regions, highlighting the need for a comprehensive epidemiological understanding to enhance diagnostic and treatment strategies. Objectives: This retrospective study aimed to investigate the prevalence and frequency of neurological disorders in dogs referred to the Veterinary Teaching Hospital. Methods: This study analyzed records from 13,430 patients referred to the hospital. Among these, 9131 cases involved dogs. Of these, 422 dogs had neurological disorders, and their records were analyzed for the study. Results: The prosencephalon was the most commonly affected location (81 cases, 19.6%), followed by multifocal involvement (62 cases, 15%) and the T3‐L3 spinal cord (56 cases, 13.5%). Infectious diseases, especially canine distemper diseases, were the most common cause, accounting for 136 cases (33.2%). Unknown causes ranked second (66 cases, 15.9%), with trauma third (56 cases, 13.3%). Other neurological disorders included intervertebral disc displacement, polyradiculoneuritis, vestibular injury, and poisoning. Notably, although most affected dogs (81.3%) were under 5 years of age, the relative prevalence of neurological disorders increased with advancing age. Conclusion: Infectious diseases, especially canine distemper, trauma, and unknown causes, are the primary contributors to neurological disorders in this region. The observed high prevalence of these conditions contrasts with the findings from other regions, emphasizing the need for improved prevention and treatment strategies. Furthermore, many neurological disorders affecting the prosencephalon can be effectively diagnosed and managed through basic neurological examinations without necessitating advanced imaging techniques.
- 28 April 2026
- Published by Wiley in Veterinary Medicine and Science
- Vol. 12 (3) , e70952
Open AccessNeurological Disorders in Dogs: A Retrospective Analysis of Prevalence, Aetiology, Lesion Locations, and Regional Variations in Northeastern Iran
Background: Neurological disorders in dogs are a significant concern in veterinary medicine and affect various breeds and ages. Previous studies have reported differing prevalence rates and aetiologies across regions, highlighting the need for a comprehensive epidemiological understanding to enhance diagnostic and treatment strategies. Objectives: This retrospective study aimed to investigate the prevalence and frequency of neurological disorders in dogs referred to the Veterinary Teaching Hospital. Methods: This study analyzed records from 13,430 patients referred to the hospital. Among these, 9131 cases involved dogs. Of these, 422 dogs had neurological disorders, and their records were analyzed for the study. Results: The prosencephalon was the most commonly affected location (81 cases, 19.6%), followed by multifocal involvement (62 cases, 15%) and the T3‐L3 spinal cord (56 cases, 13.5%). Infectious diseases, especially canine distemper diseases, were the most common cause, accounting for 136 cases (33.2%). Unknown causes ranked second (66 cases, 15.9%), with trauma third (56 cases, 13.3%). Other neurological disorders included intervertebral disc displacement, polyradiculoneuritis, vestibular injury, and poisoning. Notably, although most affected dogs (81.3%) were under 5 years of age, the relative prevalence of neurological disorders increased with advancing age. Conclusion: Infectious diseases, especially canine distemper, trauma, and unknown causes, are the primary contributors to neurological disorders in this region. The observed high prevalence of these conditions contrasts with the findings from other regions, emphasizing the need for improved prevention and treatment strategies. Furthermore, many neurological disorders affecting the prosencephalon can be effectively diagnosed and managed through basic neurological examinations without necessitating advanced imaging techniques.
- Open Access
- 20 August 2025
- Published by Wiley in Veterinary Medicine and Science
- Vol. 11 (5) , e70479
Effects of Phenobarbital and Prednisolone on Neurological Signs of Canine Distemper
Background: Canine distemper virus (CDV) is a highly infectious and often fatal disease in dogs, affecting various systems. Despite vaccination efforts, cases of distemper, especially the neurological form, remain a global concern due to its high fatality rate.Objective: To investigate the effectiveness of phenobarbital and prednisolone in treating the neurological form of canine distemper (CD).Methods: Thirty‐five dogs with neurological signs of CD were included in the study after careful clinical examination. Confirmation of CD was based on clinical signs, rapid diagnostic tests, and RT‐PCR testing of blood and/or cerebrospinal fluid (CSF). Dogs were treated with oral phenobarbital (2.5 mg/kg) and prednisolone (0.55 mg/kg) every 12 h. Treatment outcomes were categorised as recovered, died, or euthanised.Results: Out of the 35 dogs, 25 tested positive for CDV. Among positive cases (n = 25), two dogs mostly recovered, one dog partially recovered, one dog remained unchanged, 18 died (15 died naturally and three were euthanised), and three dogs were lost to follow‐up. In the negative test group (10 dogs), eight dogs died, the outcome of one dog was unknown and one dog remained unchanged. Disease duration ranged from 2 to 586 days (average: 72 days in positive cases, 59.2 days in negative cases). The low recovery rate (8%) suggests limited effectiveness of the treatments used, including prednisolone, particularly for myoclonus, which was the most frequent clinical sign. Regarding seizure management, while our study observed some effectiveness of phenobarbital in controlling seizures, it's important to note that the efficacy of phenobarbital can vary.Limitations: Small sample size and owner non‐compliance limited the study.Conclusions: Our findings suggest limited benefit from prednisolone for neurological CD. Further research is necessary to develop more effective treatment strategies for this devastating canine viral disease.
- 20 August 2025
- Published by Wiley in Veterinary Medicine and Science
- Vol. 11 (5) , e70479
Open AccessEffects of Phenobarbital and Prednisolone on Neurological Signs of Canine Distemper
Background: Canine distemper virus (CDV) is a highly infectious and often fatal disease in dogs, affecting various systems. Despite vaccination efforts, cases of distemper, especially the neurological form, remain a global concern due to its high fatality rate.Objective: To investigate the effectiveness of phenobarbital and prednisolone in treating the neurological form of canine distemper (CD).Methods: Thirty‐five dogs with neurological signs of CD were included in the study after careful clinical examination. Confirmation of CD was based on clinical signs, rapid diagnostic tests, and RT‐PCR testing of blood and/or cerebrospinal fluid (CSF). Dogs were treated with oral phenobarbital (2.5 mg/kg) and prednisolone (0.55 mg/kg) every 12 h. Treatment outcomes were categorised as recovered, died, or euthanised.Results: Out of the 35 dogs, 25 tested positive for CDV. Among positive cases (n = 25), two dogs mostly recovered, one dog partially recovered, one dog remained unchanged, 18 died (15 died naturally and three were euthanised), and three dogs were lost to follow‐up. In the negative test group (10 dogs), eight dogs died, the outcome of one dog was unknown and one dog remained unchanged. Disease duration ranged from 2 to 586 days (average: 72 days in positive cases, 59.2 days in negative cases). The low recovery rate (8%) suggests limited effectiveness of the treatments used, including prednisolone, particularly for myoclonus, which was the most frequent clinical sign. Regarding seizure management, while our study observed some effectiveness of phenobarbital in controlling seizures, it's important to note that the efficacy of phenobarbital can vary.Limitations: Small sample size and owner non‐compliance limited the study.Conclusions: Our findings suggest limited benefit from prednisolone for neurological CD. Further research is necessary to develop more effective treatment strategies for this devastating canine viral disease.
- Open Access
- 24 September 2024
- Published by Wiley in Veterinary Medicine and Science
- Vol. 10 (6) , e70009
Effects of acepromazine, xylazine and propofol on spinal reflexes in healthy dogs
Background: In the neurological examination, it is crucial to identify the possible location of the lesion in order to determine the appropriate treatment process. In aggressive animals, chemical restraint may be necessary due to their non‐cooperative behaviour. However, sedatives may distort the results of examinations. Therefore, a drug should be found that has minimal impact on the examination results.Objectives: To investigate the effects of acepromazine, xylazine, and propofol on spinal reflexes in healthy dogs.Methods: In a randomized, blinded study, ten native adult mixed‐breed dogs were participated in three groups with a 1‐week washout period between each group. Before performing each step, the spinal reflexes were evaluated. Then, in the first group, acepromazine (0.05 mg/kg, IM), in the second group, xylazine (1 mg/kg, IM), and in the third group, propofol (3 mg/kg, IV for initial bolus and 0.1 mg/kg/min for maintenance) were injected for sedation. The spinal reflexes were reevaluated at maximum sedation and at 15, 30, and 45 min thereafter.Results: Acepromazine increased the patellar reflex and decreased the panniculus reflex. Xylazine increased the cranial tibial reflex and decreased the panniculus reflex, while propofol decreased the withdrawal, and extensor carpi radialis reflexes, and suppressed the palpebral and gag reflexes.Conclusions: The drugs used in the present study did not have a significant impact on the most important reflexes evaluated in neurological examinations. Among the drugs, acepromazine has the least effects compared to other drugs, making it a suitable choice for sedation.
- 24 September 2024
- Published by Wiley in Veterinary Medicine and Science
- Vol. 10 (6) , e70009
Open AccessEffects of acepromazine, xylazine and propofol on spinal reflexes in healthy dogs
Background: In the neurological examination, it is crucial to identify the possible location of the lesion in order to determine the appropriate treatment process. In aggressive animals, chemical restraint may be necessary due to their non‐cooperative behaviour. However, sedatives may distort the results of examinations. Therefore, a drug should be found that has minimal impact on the examination results.Objectives: To investigate the effects of acepromazine, xylazine, and propofol on spinal reflexes in healthy dogs.Methods: In a randomized, blinded study, ten native adult mixed‐breed dogs were participated in three groups with a 1‐week washout period between each group. Before performing each step, the spinal reflexes were evaluated. Then, in the first group, acepromazine (0.05 mg/kg, IM), in the second group, xylazine (1 mg/kg, IM), and in the third group, propofol (3 mg/kg, IV for initial bolus and 0.1 mg/kg/min for maintenance) were injected for sedation. The spinal reflexes were reevaluated at maximum sedation and at 15, 30, and 45 min thereafter.Results: Acepromazine increased the patellar reflex and decreased the panniculus reflex. Xylazine increased the cranial tibial reflex and decreased the panniculus reflex, while propofol decreased the withdrawal, and extensor carpi radialis reflexes, and suppressed the palpebral and gag reflexes.Conclusions: The drugs used in the present study did not have a significant impact on the most important reflexes evaluated in neurological examinations. Among the drugs, acepromazine has the least effects compared to other drugs, making it a suitable choice for sedation.
- 29 August 2024
- Published by Wiley in Veterinary Ophthalmology
- Vol. 28 (4) , 691-698
Evaluation of lidocaine for auriculopalpebral nerve block in dogs: Onset, duration, and effects on intraocular pressure and eye examination
Objectives: Accurate intraocular pressure (IOP) measurement is essential for managing glaucoma, requiring tonometry. Local anesthesia is typically used, but nerve blocks may be needed for blepharospasm. This study investigated the efficacy of auriculopalpebral nerve block with lidocaine in achieving eyelid akinesia and its influence on IOP in dogs.Animals and Procedures: In a randomized, blinded trial, 12 healthy adult mixed‐breed dogs (24 eyes) received either auriculopalpebral nerve block with 2% lidocaine (n = 12 eyes) or no block (n = 12 eyes). Tetracaine drops were used for topical anesthesia in half of blocked/non‐blocked eyes, and the rest of the eyes got artificial tears as control. The impact of nerve block was evaluated through assessments of menace response, palpebral reflex, and IOP before the block, after drop instillation, and at 15‐min intervals until block dissipation.Results: Auriculopalpebral nerve block provided effective eyelid akinesia in 58.5% (7/12 eyes) at 15 min, reaching 91.7% (11/12 eyes) at 30 min, indicating peak efficacy. Subsequently, the block gradually diminished, with 66.7% (8/12 eyes) and 33.3% (4/12 eyes) maintaining akinesia at 45 and 60 min, respectively. Importantly, neither auriculopalpebral nerve block nor tetracaine administration significantly affected IOP measurements (p > .05).Conclusions: Auriculopalpebral nerve block using lidocaine demonstrated efficient eyelid akinesia, peaking at 30 min postinjection. This technique proved to be safe with no notable alterations in IOP, suggesting its potential utility in canine ophthalmology for procedures requiring eyelid akinesia, particularly in the management of glaucoma where maintaining accurate IOP measurements is crucial for diagnosis, treatment, and monitoring the disease.
- 29 August 2024
- Published by Wiley in Veterinary Ophthalmology
- Vol. 28 (4) , 691-698
Evaluation of lidocaine for auriculopalpebral nerve block in dogs: Onset, duration, and effects on intraocular pressure and eye examination
Objectives: Accurate intraocular pressure (IOP) measurement is essential for managing glaucoma, requiring tonometry. Local anesthesia is typically used, but nerve blocks may be needed for blepharospasm. This study investigated the efficacy of auriculopalpebral nerve block with lidocaine in achieving eyelid akinesia and its influence on IOP in dogs.Animals and Procedures: In a randomized, blinded trial, 12 healthy adult mixed‐breed dogs (24 eyes) received either auriculopalpebral nerve block with 2% lidocaine (n = 12 eyes) or no block (n = 12 eyes). Tetracaine drops were used for topical anesthesia in half of blocked/non‐blocked eyes, and the rest of the eyes got artificial tears as control. The impact of nerve block was evaluated through assessments of menace response, palpebral reflex, and IOP before the block, after drop instillation, and at 15‐min intervals until block dissipation.Results: Auriculopalpebral nerve block provided effective eyelid akinesia in 58.5% (7/12 eyes) at 15 min, reaching 91.7% (11/12 eyes) at 30 min, indicating peak efficacy. Subsequently, the block gradually diminished, with 66.7% (8/12 eyes) and 33.3% (4/12 eyes) maintaining akinesia at 45 and 60 min, respectively. Importantly, neither auriculopalpebral nerve block nor tetracaine administration significantly affected IOP measurements (p > .05).Conclusions: Auriculopalpebral nerve block using lidocaine demonstrated efficient eyelid akinesia, peaking at 30 min postinjection. This technique proved to be safe with no notable alterations in IOP, suggesting its potential utility in canine ophthalmology for procedures requiring eyelid akinesia, particularly in the management of glaucoma where maintaining accurate IOP measurements is crucial for diagnosis, treatment, and monitoring the disease.
- Open Access
- 27 November 2023
- Published by Wiley in Veterinary Medicine and Science
- Vol. 10 (1)
Influence of ketamine, propofol or isoflurane on intraocular pressure, heart rate and blood pressure in healthy dogs premedicated with medetomidine and midazolam
Background: According to the findings of several studies, sedatives and anaesthetics have different effects on the functioning of the cardiovascular system and intraocular pressure (IOP). For accurate diagnosis, treatment and surgery with minimal complications, it is necessary to be aware of the effects of sedatives and anaesthetics on the cardiovascular system and IOP.Objectives: The aim of this study was to evaluate the effects of sedatives (medetomidine and midazolam) and anaesthetics (ketamine, propofol and isoflurane) on IOP, heart rate (HR) and blood pressure in dogs.Methods: In this study, 10 dogs participated in three treatments using a randomised cross‐over design, with a 1‐week washout period between each treatment. Dogs in all treatments were premedicated with medetomidine and midazolam. Anaesthesia was induced using ketamine, propofol, or isoflurane and maintained for 60 min with the appropriate doses of each drug. The cardiovascular variables (heart rate, and systolic, diastolic and mean arterial pressures) and IOP were measured at different timepoints: before premedication (baseline values, T‐Bas), 15 min after medetomidine administration (T‐Med), 20 min after midazolam administration (T‐Mid) and at 15 (T‐15), 30 (T‐30), 45 (T‐45) and 60 (T‐60) min after anaesthesia induction.Results: Medetomidine significantly reduced the IOP and HR and did not significantly change the mean arterial pressure (MAP). Midazolam significantly reduced the IOP while did not significantly change the HR and MAP. Ketamine and isoflurane significantly increased the IOP and HR while did not significantly change the MAP. Propofol significantly increased the HR, but did not cause significant changes in IOP and MAP.Conclusions: Considering that anaesthetics are typically administered in conjunction with pre‐anaesthetic drugs, the increases in IOP induced by ketamine and isoflurane are not important, as the IOP did not exceed the baseline values. However, further studies are required to investigate these effects in patients with elevated IOP.
- 27 November 2023
- Published by Wiley in Veterinary Medicine and Science
- Vol. 10 (1)
Open AccessInfluence of ketamine, propofol or isoflurane on intraocular pressure, heart rate and blood pressure in healthy dogs premedicated with medetomidine and midazolam
Background: According to the findings of several studies, sedatives and anaesthetics have different effects on the functioning of the cardiovascular system and intraocular pressure (IOP). For accurate diagnosis, treatment and surgery with minimal complications, it is necessary to be aware of the effects of sedatives and anaesthetics on the cardiovascular system and IOP.Objectives: The aim of this study was to evaluate the effects of sedatives (medetomidine and midazolam) and anaesthetics (ketamine, propofol and isoflurane) on IOP, heart rate (HR) and blood pressure in dogs.Methods: In this study, 10 dogs participated in three treatments using a randomised cross‐over design, with a 1‐week washout period between each treatment. Dogs in all treatments were premedicated with medetomidine and midazolam. Anaesthesia was induced using ketamine, propofol, or isoflurane and maintained for 60 min with the appropriate doses of each drug. The cardiovascular variables (heart rate, and systolic, diastolic and mean arterial pressures) and IOP were measured at different timepoints: before premedication (baseline values, T‐Bas), 15 min after medetomidine administration (T‐Med), 20 min after midazolam administration (T‐Mid) and at 15 (T‐15), 30 (T‐30), 45 (T‐45) and 60 (T‐60) min after anaesthesia induction.Results: Medetomidine significantly reduced the IOP and HR and did not significantly change the mean arterial pressure (MAP). Midazolam significantly reduced the IOP while did not significantly change the HR and MAP. Ketamine and isoflurane significantly increased the IOP and HR while did not significantly change the MAP. Propofol significantly increased the HR, but did not cause significant changes in IOP and MAP.Conclusions: Considering that anaesthetics are typically administered in conjunction with pre‐anaesthetic drugs, the increases in IOP induced by ketamine and isoflurane are not important, as the IOP did not exceed the baseline values. However, further studies are required to investigate these effects in patients with elevated IOP.
- Open Access
- 1 March 2023
- Vol. 14 (3) , 153-160
Prevalence of canine distemper in dogs referred to Veterinary Hospital of Ferdowsi University of Mashhad, Mashhad, Iran
Canine distemper virus (CDV) is responsible for high morbidity and mortality in dogs worldwide. Epidemiological study of canine distemper can help to control and treat the disease in any area. This study aimed to investigate the prevalence of CDV in dogs referred to the Veterinary Hospital from September 23, 2018 to September 22, 2019. Dogs with at least two clinical signs of canine distemper underwent blood tests, rapid test kit from the eye and cerebrospinal fluid (CSF), and RT-PCR from whole blood and/or CSF samples. Out of 1212 referred dogs, 112 dogs were suspected to have canine distemper of which 90 underwent RTPCR and rapid test kits. The disease prevalence was 4.04% (49/1212) and 7.44% (49/659) according to the total number of referring dogs and number of referring sick dogs, respectively. The distemper fatality rate was 69.57% (32/46). Seventy percent of distemper positive cases were under 12 months old and 52.08% were under 6 months old. Female dogs were more susceptible than males; however, the fatality rate of males was more than females. Of distemper positive dogs, 91.84% were unvaccinated. The highest prevalence (71.43%) of dogs diagnosed with CDV occurred during the cold seasons. It is concluded that canine distemper is endemic in the geographical area of Mashhad and its prevalence rate in dogs referred to the Veterinary Hospital of Ferdowsi University of Mashhad is 4.04% and its fatality rate is 69.57%. This indicates that a significant number of dogs may die if they develop distemper despite treatment.
- 1 March 2023
- Vol. 14 (3) , 153-160
Open AccessPrevalence of canine distemper in dogs referred to Veterinary Hospital of Ferdowsi University of Mashhad, Mashhad, Iran
Canine distemper virus (CDV) is responsible for high morbidity and mortality in dogs worldwide. Epidemiological study of canine distemper can help to control and treat the disease in any area. This study aimed to investigate the prevalence of CDV in dogs referred to the Veterinary Hospital from September 23, 2018 to September 22, 2019. Dogs with at least two clinical signs of canine distemper underwent blood tests, rapid test kit from the eye and cerebrospinal fluid (CSF), and RT-PCR from whole blood and/or CSF samples. Out of 1212 referred dogs, 112 dogs were suspected to have canine distemper of which 90 underwent RTPCR and rapid test kits. The disease prevalence was 4.04% (49/1212) and 7.44% (49/659) according to the total number of referring dogs and number of referring sick dogs, respectively. The distemper fatality rate was 69.57% (32/46). Seventy percent of distemper positive cases were under 12 months old and 52.08% were under 6 months old. Female dogs were more susceptible than males; however, the fatality rate of males was more than females. Of distemper positive dogs, 91.84% were unvaccinated. The highest prevalence (71.43%) of dogs diagnosed with CDV occurred during the cold seasons. It is concluded that canine distemper is endemic in the geographical area of Mashhad and its prevalence rate in dogs referred to the Veterinary Hospital of Ferdowsi University of Mashhad is 4.04% and its fatality rate is 69.57%. This indicates that a significant number of dogs may die if they develop distemper despite treatment.
- 1 December 2022
- Vol. 13 (4) , 563-568
Evaluation of Newcastle disease virus vaccine effectiveness in dogs with neurological signs of canine distemper
Canine Distemper Virus (CDV) is the cause of a highly lethal infectious disease affecting a broad range of carnivores. Despite using various treatments, there is still no effective treatment, especially in the neurological form of distemper. The aim of this study was to evaluate the therapeutic effect of injecting Newcastle disease vaccine into the subarachnoid space of dogs with neurological form of distemper. The dogs that had symptoms of nervous distemper, particularly myoclonus, were included in the plan. After anesthetizing of dogs, 0.10 to 1.00 mL of cerebrospinal fluid (CSF) were removed and, 0.10 to 0.50 mL of the prepared Newcastle solution were injected into their subarachnoid space. Another 0.50 to 1.00 mL of normal saline was then injected to remove the needle from the vaccine. The live attenuated LaSota or B1 vaccine was used in this study. Rapid kit tests and reverse transcription polymerase chain reaction (RT-PCR) assays were used to diagnose of the disease. Dogs were monitored for up to 3 to 24 months during that time they were evaluated for improvement or worsening of clinical symptoms. Out of nine dogs in which distemper were diagnosed with different tests, one dog recovered completely and another dog recovered greatly. Therefore, the overall recovery rate was 22.20%. It is concluded that administration of Newcastle vaccine into the subarachnoid space of dogs with nervous distemper causes at least 22.20% improvement and does not cause specific side effects and can be used to treat affected dogs. (c) 2022 Urmia University. All rights reserved.
- 1 December 2022
- Vol. 13 (4) , 563-568
Evaluation of Newcastle disease virus vaccine effectiveness in dogs with neurological signs of canine distemper
Canine Distemper Virus (CDV) is the cause of a highly lethal infectious disease affecting a broad range of carnivores. Despite using various treatments, there is still no effective treatment, especially in the neurological form of distemper. The aim of this study was to evaluate the therapeutic effect of injecting Newcastle disease vaccine into the subarachnoid space of dogs with neurological form of distemper. The dogs that had symptoms of nervous distemper, particularly myoclonus, were included in the plan. After anesthetizing of dogs, 0.10 to 1.00 mL of cerebrospinal fluid (CSF) were removed and, 0.10 to 0.50 mL of the prepared Newcastle solution were injected into their subarachnoid space. Another 0.50 to 1.00 mL of normal saline was then injected to remove the needle from the vaccine. The live attenuated LaSota or B1 vaccine was used in this study. Rapid kit tests and reverse transcription polymerase chain reaction (RT-PCR) assays were used to diagnose of the disease. Dogs were monitored for up to 3 to 24 months during that time they were evaluated for improvement or worsening of clinical symptoms. Out of nine dogs in which distemper were diagnosed with different tests, one dog recovered completely and another dog recovered greatly. Therefore, the overall recovery rate was 22.20%. It is concluded that administration of Newcastle vaccine into the subarachnoid space of dogs with nervous distemper causes at least 22.20% improvement and does not cause specific side effects and can be used to treat affected dogs. (c) 2022 Urmia University. All rights reserved.
- Open Access
- 15 November 2022
- Published by Universidad Nacional Autonoma de Mexico in Veterinaria México OA
- Vol. 9
Evaluation of the anti-Newcastle disease vaccine serum on dogs with canine distemper
Distemper is a contagious, highly lethal, and almost incurable viral disease in dogs and other terrestrial carnivores. This study evaluated a new distemper treatment for dogs. Two healthy male dogs of mixed breed were prepared. A 1 000-dose vial of Newcastle disease vaccine was then diluted with 6 mL normal saline and 3 mL of it was injected into the cephalic vein of each dog, collecting 20 % of the blood volume 11 h later. Blood sera were separated and used as anti-Newcastle disease vaccine serum (ANDVS) to treat dogs suspected of having canine distemper. Dogs with confirmed distemper were grouped into the following seven treatment groups: 1- ANDVS; 2- ANDVS + Cotrimoxazole; 3- ANDVS + Penicillin-Gentamicin; 4- ANDVS + Cefazolin-Amikacin; 5- Cotrimoxazole; 6- Penicillin-Gentamycin; 7- Cefazolin-Amikacin. Then the fatality rate of dogs, association between distemper and sex, breed, age, and effects of distemper on hematological factors and vital signs were evaluated. The recovery rates in the ANDVS+ Cotrimoxazole and the ANDVS+ Cefazolin-Amikacin groups were higher than those in the ANDVS group (P < 0.05). Fatality rate was significantly different in distemper-positive and distemper-negative dogs. It is concluded that although ANDVS alone has no effect on the treatment of distemper, it can increase the recovery rate when combined with cotrimoxazole or cefazolin + amikacin as compared with the sole use of these antibiotics.
- 15 November 2022
- Published by Universidad Nacional Autonoma de Mexico in Veterinaria México OA
- Vol. 9
Open AccessEvaluation of the anti-Newcastle disease vaccine serum on dogs with canine distemper
Distemper is a contagious, highly lethal, and almost incurable viral disease in dogs and other terrestrial carnivores. This study evaluated a new distemper treatment for dogs. Two healthy male dogs of mixed breed were prepared. A 1 000-dose vial of Newcastle disease vaccine was then diluted with 6 mL normal saline and 3 mL of it was injected into the cephalic vein of each dog, collecting 20 % of the blood volume 11 h later. Blood sera were separated and used as anti-Newcastle disease vaccine serum (ANDVS) to treat dogs suspected of having canine distemper. Dogs with confirmed distemper were grouped into the following seven treatment groups: 1- ANDVS; 2- ANDVS + Cotrimoxazole; 3- ANDVS + Penicillin-Gentamicin; 4- ANDVS + Cefazolin-Amikacin; 5- Cotrimoxazole; 6- Penicillin-Gentamycin; 7- Cefazolin-Amikacin. Then the fatality rate of dogs, association between distemper and sex, breed, age, and effects of distemper on hematological factors and vital signs were evaluated. The recovery rates in the ANDVS+ Cotrimoxazole and the ANDVS+ Cefazolin-Amikacin groups were higher than those in the ANDVS group (P < 0.05). Fatality rate was significantly different in distemper-positive and distemper-negative dogs. It is concluded that although ANDVS alone has no effect on the treatment of distemper, it can increase the recovery rate when combined with cotrimoxazole or cefazolin + amikacin as compared with the sole use of these antibiotics.
- Open Access
- 22 September 2022
- Published by Wiley in Veterinary Medicine and Science
- Vol. 8 (6) , 2360-2366
The effects of age, sex, breed, diet, reproductive status and housing condition on the amounts of 25(OH) vitamin D in the serum of healthy dogs: Reference values
Background: Optimal amount of vitamin D for the proper functioning of the immune system is different from the required vitamin D amount for bones to prevent rickets. However, reports on vitamin D reference values in dogs are minimal, and there is still not enough information regarding the relationship between vitamin D and various variables such as disease, age, breed, diet type, and so on, as well as its relationship with haematological and serum biochemical parameters.Obgectives: The present study aimed to determine reference values of 25(OH) Vit D in dogs and its concentration in different groups, categorized based on age, sex, breed, housing conditions, and diet, as well as 25(OH) Vit D relationship with hematology and serum biochemistry parameters.Methods: In this study, 90 healthy dogs were selected to determine the reference value of 25 (OH) Vit D of serum after evaluating of their haematological and biochemical parameters to assess their general health. Dogs were divided into different groups according to above‐mentioned variables. Serum 25 (OH) Vit D was subsequently measured by the ELISA method.Results: The median concentration of 25 (OH) Vit D was 52.50 ng/ml with minimum and maximum amounts of 14.00 and 155.57 ng/ml, respectively. No significant difference was observed between 25 (OH) Vit D levels in the studied dogs regarding their different age, sex, breed, diet, housing condition, and reproductive status. Serum 25 (OH) Vit D concentration is directly correlated with the number of band neutrophils (p < 0.05). We also witnessed indirect correlations between serum 25 (OH) Vit D levels and the number of blood eosinophils and serum glucose (p < 0.05).Conclusion: In the present study age, sex, breed, housing condition and age had no significant effects on the amounts of 25(OH) vitamin D. According to correlations of vitamin D with MCH, band and eosinophil numbers and glucose, vitamin D may have a role in erythropoiesis and leukocytes response and also in energy metabolism in dog.
- 22 September 2022
- Published by Wiley in Veterinary Medicine and Science
- Vol. 8 (6) , 2360-2366
Open AccessThe effects of age, sex, breed, diet, reproductive status and housing condition on the amounts of 25(OH) vitamin D in the serum of healthy dogs: Reference values
Background: Optimal amount of vitamin D for the proper functioning of the immune system is different from the required vitamin D amount for bones to prevent rickets. However, reports on vitamin D reference values in dogs are minimal, and there is still not enough information regarding the relationship between vitamin D and various variables such as disease, age, breed, diet type, and so on, as well as its relationship with haematological and serum biochemical parameters.Obgectives: The present study aimed to determine reference values of 25(OH) Vit D in dogs and its concentration in different groups, categorized based on age, sex, breed, housing conditions, and diet, as well as 25(OH) Vit D relationship with hematology and serum biochemistry parameters.Methods: In this study, 90 healthy dogs were selected to determine the reference value of 25 (OH) Vit D of serum after evaluating of their haematological and biochemical parameters to assess their general health. Dogs were divided into different groups according to above‐mentioned variables. Serum 25 (OH) Vit D was subsequently measured by the ELISA method.Results: The median concentration of 25 (OH) Vit D was 52.50 ng/ml with minimum and maximum amounts of 14.00 and 155.57 ng/ml, respectively. No significant difference was observed between 25 (OH) Vit D levels in the studied dogs regarding their different age, sex, breed, diet, housing condition, and reproductive status. Serum 25 (OH) Vit D concentration is directly correlated with the number of band neutrophils (p < 0.05). We also witnessed indirect correlations between serum 25 (OH) Vit D levels and the number of blood eosinophils and serum glucose (p < 0.05).Conclusion: In the present study age, sex, breed, housing condition and age had no significant effects on the amounts of 25(OH) vitamin D. According to correlations of vitamin D with MCH, band and eosinophil numbers and glucose, vitamin D may have a role in erythropoiesis and leukocytes response and also in energy metabolism in dog.
- Open Access
- 9 September 2022
- Published by Wiley in Veterinary Medicine and Science
- Vol. 8 (6) , 2351-2359
Effect of medetomidine, midazolam, ketamine, propofol and isoflurane on spinal reflexes in healthy dogs
Background: Sometimes it is necessary to use sedatives or even general anaesthetics to examine animals with spinal cord injuries. These drugs may affect spinal reflexes, alter the outcome of neurological examinations, and make it difficult to diagnose location of the lesion. Objectives: The aim of this study was to evaluate the effects of five pre-anaesthetic and anaesthetic agents commonly used in clinics on spinal reflexes in dogs. Methods: Ten native adult dogs were participated in three groups. In all groups, the dogs were premeditated with medetomidine and midazolam; then, in the first group, ketamine, in the second group, propofol and in the third group, isoflurane were used for induction of anaesthesia. The spinal reflexes were evaluated before injection, 15 min after medetomidine, 20 min after midazolam, and at 15, 30, 45 and 60 min after induction of anaesthesia. Results: Medetomidine did not reduce monosynaptic reflexes (patellar and cranial tibial reflexes) but increased them while it had no effect on the polysynaptic limb withdrawal reflexes. Midazolam had no effect on the spinal reflexes; Ketamine did not affect the patellar, cranial tibial and extensor carpi radialis reflexes, but reduced polysynaptic pain-related reflexes; and propofol and isoflurane abolished the all spinal reflexes. Conclusions: Medetomidine, midazolam and ketamine have no effect on reducing monosynaptic reflexes (patellar and cranial tibial reflexes) and may be used for neurological examination of restless animals in the clinic. Propofol and isoflurane eliminated all spinal reflex responses and are not suitable for neurological examinations.
- 9 September 2022
- Published by Wiley in Veterinary Medicine and Science
- Vol. 8 (6) , 2351-2359
Open AccessEffect of medetomidine, midazolam, ketamine, propofol and isoflurane on spinal reflexes in healthy dogs
Background: Sometimes it is necessary to use sedatives or even general anaesthetics to examine animals with spinal cord injuries. These drugs may affect spinal reflexes, alter the outcome of neurological examinations, and make it difficult to diagnose location of the lesion. Objectives: The aim of this study was to evaluate the effects of five pre-anaesthetic and anaesthetic agents commonly used in clinics on spinal reflexes in dogs. Methods: Ten native adult dogs were participated in three groups. In all groups, the dogs were premeditated with medetomidine and midazolam; then, in the first group, ketamine, in the second group, propofol and in the third group, isoflurane were used for induction of anaesthesia. The spinal reflexes were evaluated before injection, 15 min after medetomidine, 20 min after midazolam, and at 15, 30, 45 and 60 min after induction of anaesthesia. Results: Medetomidine did not reduce monosynaptic reflexes (patellar and cranial tibial reflexes) but increased them while it had no effect on the polysynaptic limb withdrawal reflexes. Midazolam had no effect on the spinal reflexes; Ketamine did not affect the patellar, cranial tibial and extensor carpi radialis reflexes, but reduced polysynaptic pain-related reflexes; and propofol and isoflurane abolished the all spinal reflexes. Conclusions: Medetomidine, midazolam and ketamine have no effect on reducing monosynaptic reflexes (patellar and cranial tibial reflexes) and may be used for neurological examination of restless animals in the clinic. Propofol and isoflurane eliminated all spinal reflex responses and are not suitable for neurological examinations.